Studies have indicated a tumor-suppressing role of RUNX3 [20] and complete inactivation or downregulation of RUNX3 gene has been associated with gastric cancer [17], CaEs [21, 22] pancreatic cancer [23]. This evidence concerns the gene RUNX3 and gastric cancer.